STLN · Starling Oncology Inc. Common Stock
View on chartInsiders & Stakes
| Jorey Chernett 10% Owner | ▲ Buy | Open Market | 10,660,858 Shares held | 8/14/2026 | View profile |
| M33 Growth I L.P. Director | ▼ Sell | Other | 5,444,207 Shares held | 11/18/2025 | View profile |
| BARASCH RICHARD A Director | ▼ Sell | Other | 2,635,881 Shares held | 7/24/2025 | View profile |
| Virnich Daniel Chief Operating Officer | ▼ Sell | Other | 2,337,166 Shares held | 5/21/2026 | View profile |
| Shah Mihir Chief Financial Officer | ▲ Buy | Grant | 474,931 Shares held | 5/21/2024 | View profile |
| Carter Robert Ross Chief Financial Officer | ▼ Sell | Other | 414,801 Shares held | 5/21/2026 | View profile |
| Hively Brad Chief Executive Officer | ▼ Sell | Open Market | 411,976 Shares held | 8/21/2026 | View profile |
| Ling Gabriel Director | ▲ Buy | Grant | 333,539 Shares held | 11/20/2025 | View profile |
| Anne McGeorge | ▲ Buy | Grant | 332,535 Shares held | 7/27/2026 | View profile |
| Johnson Karen Marie Director | ▲ Buy | Grant | 319,410 Shares held | 7/27/2026 | View profile |
| Pacala Mark L Director | ▲ Buy | Grant | 286,881 Shares held | 7/27/2026 | View profile |
| Podnos Yale Chief Medical Officer | ▼ Sell | Open Market | 259,527 Shares held | 7/14/2026 | View profile |
| Agajanian Richy 10% Owner | ▼ Sell | Open Market | 253,436 Shares held | 5/11/2022 | View profile |
| Havencrest Healthcare Partners, L.P. 10% Owner | ▼ Sell | Other | 252,626 Shares held | 8/16/2024 | View profile |
| Castle Jeremy Chief Operating Officer | ▼ Sell | Other | 247,031 Shares held | 5/21/2025 | View profile |
| Miller Matthew P Chief Operating Officer | ▲ Buy | Grant | 242,992 Shares held | 3/17/2023 | View profile |
| Kaushal Mohit Director | ▲ Buy | Grant | 205,716 Shares held | 7/27/2026 | View profile |
| England Kristin Chief Administrative Officer | ▲ Buy | Grant | 153,780 Shares held | 3/27/2026 | View profile |
| Dalgleish Scott Chief Financial Officer | ▲ Buy | Grant | 151,008 Shares held | 3/21/2022 | View profile |
| Langsam Jeffrey Chief Clinical Officer | ▲ Buy | Grant | 127,650 Shares held | 3/27/2026 | View profile |
| O'Meara Maeve Director | ▲ Buy | Grant | 109,104 Shares held | 12/26/2023 | View profile |
| James E. Flynn 10% Owner | ▼ Sell | Other | 85,113 Shares held | 11/12/2021 | View profile |
| SARIN RAVI YANG Director | ▲ Buy | Grant | 75,427 Shares held | 3/17/2023 | View profile |
| Mark Stolper Executive VP and CFO | ▲ Buy | Grant | 56,957 Shares held | 7/27/2026 | View profile |
| TZOUMAKAS KIMBERLY JO Director | ▲ Buy | Grant | 46,301 Shares held | 7/27/2026 | View profile |
| Simoneit Diona Chief Accounting Officer | ▲ Buy | Grant | 39,705 Shares held | 11/17/2022 | View profile |
| DFP Sponsor LLC 10% Owner | ▼ Sell | Other | 40 Shares held | 11/12/2021 | View profile |
Transaction History
| Hively Brad | ▼ Sell | Open Market | 298,853 | $1.9M | 8/21/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 12,000 | $78K | 8/14/2026 |
| Kaushal Mohit | ▲ Buy | Grant | 33,133 | $0 | 7/27/2026 |
| Anne McGeorge | ▲ Buy | Grant | 41,165 | $0 | 7/27/2026 |
| Pacala Mark L | ▲ Buy | Grant | 30,120 | $0 | 7/27/2026 |
| Mark Stolper | ▲ Buy | Grant | 31,124 | $0 | 7/27/2026 |
| TZOUMAKAS KIMBERLY JO | ▲ Buy | Grant | 29,116 | $0 | 7/27/2026 |
| Hively Brad | ▲ Buy | Grant | 27,108 | $0 | 7/27/2026 |
| Johnson Karen Marie | ▲ Buy | Grant | 31,124 | $0 | 7/27/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 18,000 | $95K | 7/21/2026 |
| Podnos Yale | ▲ Buy | Option Exercise | 17,974 | $34K | 7/14/2026 |
| Podnos Yale | ▼ Sell | Open Market | 5,478 | $35K | 7/14/2026 |
| Podnos Yale | ▼ Sell | Open Market | 17,974 | $116K | 7/14/2026 |
| Podnos Yale | ▲ Buy | Option Exercise | 5,478 | $11K | 7/14/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 15,000 | $88K | 7/10/2026 |
| TZOUMAKAS KIMBERLY JO | ▲ Buy | Grant | 17,185 | $0 | 7/7/2026 |
| Mark Stolper | ▲ Buy | Grant | 25,833 | $0 | 7/7/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 18,000 | $90K | 6/23/2026 |
| Podnos Yale | ▼ Sell | Open Market | 23,451 | $126K | 6/8/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 12,000 | $57K | 6/4/2026 |
| Virnich Daniel | ▼ Sell | Other | 23,058 | $103K | 5/21/2026 |
| Carter Robert Ross | ▼ Sell | Other | 1,604 | $7K | 5/21/2026 |
| Podnos Yale | ▼ Sell | Other | 1,805 | $8K | 5/21/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 33,500 | $136K | 5/20/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 5,000 | $20K | 5/19/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 30,000 | $123K | 5/19/2026 |
| Kaushal Mohit | ▼ Sell | Open Market | 38,433 | $135K | 4/16/2026 |
| Kaushal Mohit | ▼ Sell | Open Market | 57,286 | $201K | 4/14/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 20,000 | $62K | 4/9/2026 |
| Langsam Jeffrey | ▲ Buy | Grant | 70,270 | $0 | 3/27/2026 |
| Podnos Yale | ▲ Buy | Grant | 66,446 | $0 | 3/27/2026 |
| Carter Robert Ross | ▲ Buy | Grant | 202,914 | $0 | 3/27/2026 |
| Carter Robert Ross | ▼ Sell | Other | 20,320 | $62K | 3/27/2026 |
| Virnich Daniel | ▼ Sell | Other | 98,534 | $302K | 3/27/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 27,429 | $81K | 3/27/2026 |
| England Kristin | ▲ Buy | Grant | 55,743 | $0 | 3/27/2026 |
| Virnich Daniel | ▲ Buy | Grant | 670,608 | $0 | 3/27/2026 |
| Podnos Yale | ▼ Sell | Other | 16,173 | $50K | 3/27/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 50,000 | $158K | 3/26/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 125,000 | $389K | 3/24/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 25,000 | $84K | 3/20/2026 |
| Virnich Daniel | ▼ Sell | Other | 11,834 | $42K | 3/17/2026 |
| Carter Robert Ross | ▼ Sell | Other | 1,314 | $5K | 3/17/2026 |
| Podnos Yale | ▼ Sell | Other | 3,420 | $12K | 3/17/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 75,000 | $257K | 3/17/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 60,985 | $201K | 3/16/2026 |
| Jorey Chernett | ▲ Buy | Open Market | 263,000 | $768K | 3/13/2026 |
| Carter Robert Ross | ▼ Sell | Open Market | 247 | $879 | 1/2/2026 |
| Hively Brad | ▼ Sell | Open Market | 13,333 | $50K | 12/15/2025 |
| Anne McGeorge | ▲ Buy | Grant | 67,901 | $0 | 11/20/2025 |
| Anne McGeorge | ▲ Buy | Grant | 40,123 | $0 | 11/20/2025 |
| Kaushal Mohit | ▲ Buy | Grant | 50,926 | $0 | 11/20/2025 |
| Kaushal Mohit | ▲ Buy | Grant | 40,123 | $0 | 11/20/2025 |
| Ling Gabriel | ▲ Buy | Grant | 46,296 | $0 | 11/20/2025 |
| Ling Gabriel | ▲ Buy | Grant | 37,037 | $0 | 11/20/2025 |
| Johnson Karen Marie | ▲ Buy | Grant | 47,840 | $0 | 11/20/2025 |
| Johnson Karen Marie | ▲ Buy | Grant | 37,037 | $0 | 11/20/2025 |
| Pacala Mark L | ▲ Buy | Grant | 46,296 | $0 | 11/20/2025 |
| Pacala Mark L | ▲ Buy | Grant | 35,494 | $0 | 11/20/2025 |
| Hively Brad | ▲ Buy | Grant | 41,667 | $0 | 11/20/2025 |
| Hively Brad | ▲ Buy | Grant | 32,407 | $0 | 11/20/2025 |
| Pacala Mark L | ▼ Sell | Open Market | 2,160 | $9K | 11/18/2025 |
| Pacala Mark L | ▼ Sell | Open Market | 1,210 | $5K | 11/18/2025 |
| Pacala Mark L | ▼ Sell | Open Market | 46,630 | $187K | 11/18/2025 |
| M33 Growth I L.P. | ▼ Sell | Other | 11,818 | — | 11/18/2025 |
| M33 Growth I L.P. | ▼ Sell | Other | 2,500,000 | — | 11/18/2025 |
| M33 Growth I L.P. | ▼ Sell | Other | 590,892 | — | 11/18/2025 |
| Ling Gabriel | ▼ Sell | Other | 141,149 | — | 11/18/2025 |
| Virnich Daniel | ▲ Buy | Grant | 6,464 | $0 | 11/17/2025 |
| Podnos Yale | ▲ Buy | Grant | 2,086 | $0 | 11/17/2025 |
| Carter Robert Ross | ▲ Buy | Grant | 195 | $0 | 11/17/2025 |
| Virnich Daniel | ▲ Buy | Grant | 6,211 | $0 | 11/12/2025 |
| Podnos Yale | ▲ Buy | Grant | 306 | $0 | 11/12/2025 |
| Podnos Yale | ▲ Buy | Grant | 1,202 | $0 | 11/12/2025 |
| M33 Growth I L.P. | ▼ Sell | Open Market | 6,018,168 | $18.6M | 9/4/2025 |
| M33 Growth I L.P. | ▼ Sell | Open Market | 681,832 | $2.1M | 9/4/2025 |
| Hively Brad | ▼ Sell | Open Market | 20,221 | $82K | 8/19/2025 |
| BARASCH RICHARD A | ▼ Sell | Other | 287,756 | $0 | 7/24/2025 |
| England Kristin | ▲ Buy | Grant | 98,037 | $0 | 7/22/2025 |
| BARASCH RICHARD A | ▼ Sell | Other | 620,400 | $0 | 6/18/2025 |
| BARASCH RICHARD A | ▼ Sell | Other | 159,500 | $0 | 6/17/2025 |
| BARASCH RICHARD A | ▼ Sell | Other | 679,224 | $814K | 6/17/2025 |
| BARASCH RICHARD A | ▼ Sell | Tax Withholding | 311,128 | $814K | 6/17/2025 |
| M33 Growth I L.P. | ▼ Sell | Open Market | 673,676 | $2.1M | 6/5/2025 |
| M33 Growth I L.P. | ▼ Sell | Open Market | 76,324 | $233K | 6/5/2025 |
| Hively Brad | ▲ Buy | Option Exercise | 684,528 | $582K | 6/3/2025 |
| Hively Brad | ▲ Buy | Option Exercise | 105,320 | $51K | 6/3/2025 |
| Hively Brad | ▲ Buy | Option Exercise | 131,297 | $246K | 6/3/2025 |
| Hively Brad | ▼ Sell | Open Market | 1,867,605 | $5.4M | 6/3/2025 |
| Hively Brad | ▼ Sell | Open Market | 108,532 | $312K | 6/3/2025 |
| Hively Brad | ▲ Buy | Option Exercise | 946,460 | $804K | 6/3/2025 |
| Langsam Jeffrey | ▲ Buy | Grant | 57,380 | $0 | 5/21/2025 |
| Virnich Daniel | ▼ Sell | Other | 20,388 | $55K | 5/21/2025 |
| Podnos Yale | ▼ Sell | Other | 1,801 | $5K | 5/21/2025 |
| Carter Robert Ross | ▼ Sell | Other | 1,601 | $4K | 5/21/2025 |
| Castle Jeremy | ▼ Sell | Other | 5,636 | $15K | 5/21/2025 |
| M33 Growth I L.P. | ▼ Sell | Open Market | 1,796,468 | $4.9M | 5/20/2025 |
| M33 Growth I L.P. | ▼ Sell | Open Market | 203,532 | $552K | 5/20/2025 |
| Podnos Yale | ▲ Buy | Grant | 157,088 | $0 | 3/31/2025 |
| Carter Robert Ross | ▲ Buy | Grant | 197,368 | $0 | 3/31/2025 |
| Castle Jeremy | ▲ Buy | Grant | 162,281 | $0 | 3/31/2025 |
| Virnich Daniel | ▲ Buy | Grant | 1,083,334 | $0 | 3/31/2025 |
| M33 Growth I L.P. | ▲ Buy | Grant | 2,716,898 | $2.8M | 3/26/2025 |
| Virnich Daniel | ▲ Buy | Open Market | 22,640 | $24K | 3/26/2025 |
| Podnos Yale | ▲ Buy | Open Market | 9,056 | $9K | 3/26/2025 |
| Pacala Mark L | ▲ Buy | Open Market | 90,562 | $94K | 3/26/2025 |
| Johnson Karen Marie | ▲ Buy | Open Market | 36,224 | $38K | 3/26/2025 |
| Hively Brad | ▲ Buy | Open Market | 9,056 | $9K | 3/26/2025 |
| Castle Jeremy | ▲ Buy | Open Market | 9,056 | $9K | 3/26/2025 |
| Carter Robert Ross | ▲ Buy | Open Market | 9,056 | $9K | 3/26/2025 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 1,358,448 | $1.4M | 3/26/2025 |
| Virnich Daniel | ▼ Sell | Other | 10,261 | $9K | 3/19/2025 |
| Podnos Yale | ▼ Sell | Other | 2,975 | $3K | 3/19/2025 |
| Carter Robert Ross | ▼ Sell | Other | 1,150 | $1K | 3/19/2025 |
| Carter Robert Ross | ▼ Sell | Other | 258 | $86 | 1/6/2025 |
| Castle Jeremy | ▼ Sell | Other | 1,130 | $181 | 12/3/2024 |
| Hively Brad | ▲ Buy | Open Market | 50,000 | $8K | 12/2/2024 |
| Hively Brad | ▲ Buy | Open Market | 250,000 | $43K | 11/26/2024 |
| BARASCH RICHARD A | ▲ Buy | Grant | 80,000 | $0 | 11/22/2024 |
| Pacala Mark L | ▲ Buy | Grant | 50,000 | $0 | 11/22/2024 |
| Anne McGeorge | ▲ Buy | Grant | 56,000 | $0 | 11/22/2024 |
| Johnson Karen Marie | ▲ Buy | Grant | 52,000 | $0 | 11/22/2024 |
| Hively Brad | ▲ Buy | Grant | 44,000 | $0 | 11/22/2024 |
| Kaushal Mohit | ▲ Buy | Grant | 56,000 | $0 | 11/22/2024 |
| Ling Gabriel | ▲ Buy | Grant | 40,000 | $0 | 11/22/2024 |
| Virnich Daniel | ▼ Sell | Other | 4,977 | $677 | 11/20/2024 |
| Carter Robert Ross | ▼ Sell | Other | 235 | $32 | 11/20/2024 |
| Podnos Yale | ▼ Sell | Other | 1,709 | $232 | 11/20/2024 |
| Podnos Yale | ▼ Sell | Other | 267 | $36 | 11/20/2024 |
| Podnos Yale | ▼ Sell | Other | 1,026 | $140 | 11/20/2024 |
| Virnich Daniel | ▼ Sell | Other | 4,750 | $646 | 11/20/2024 |
| Podnos Yale | ▼ Sell | Other | 17,039 | $0 | 11/12/2024 |
| Pacala Mark L | ▼ Sell | Other | 20,248 | $0 | 11/12/2024 |
| Pacala Mark L | ▼ Sell | Other | 30,372 | $0 | 11/12/2024 |
| Virnich Daniel | ▼ Sell | Other | 78,094 | $0 | 11/12/2024 |
| Virnich Daniel | ▼ Sell | Other | 117,142 | $0 | 11/12/2024 |
| Podnos Yale | ▼ Sell | Other | 11,359 | $0 | 11/12/2024 |
| Hively Brad | ▼ Sell | Other | 353,450 | $0 | 11/12/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Other | 8,701,823 | $0 | 8/16/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Other | 7,631,418 | $0 | 8/16/2024 |
| Hively Brad | ▼ Sell | Other | 18,121 | $8K | 6/17/2024 |
| Hively Brad | ▼ Sell | Other | 19,526 | $11K | 5/22/2024 |
| Virnich Daniel | ▼ Sell | Other | 11,173 | $7K | 5/21/2024 |
| Virnich Daniel | ▲ Buy | Grant | 198,517 | $0 | 5/21/2024 |
| Castle Jeremy | ▲ Buy | Grant | 70,120 | $0 | 5/21/2024 |
| Podnos Yale | ▲ Buy | Grant | 17,530 | $0 | 5/21/2024 |
| Shah Mihir | ▲ Buy | Grant | 151,459 | $0 | 5/21/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Open Market | 8,637 | $18K | 1/29/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Open Market | 6,979 | $15K | 1/26/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Open Market | 11,882 | $25K | 1/25/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Open Market | 24,915 | $57K | 1/24/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Open Market | 5,338 | $11K | 1/23/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Open Market | 10,263 | $22K | 1/22/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Open Market | 11,986 | $26K | 1/19/2024 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Other | 3,999,998 | $0 | 12/28/2023 |
| Havencrest Healthcare Partners, L.P. | ▼ Sell | Other | 4,561,050 | $0 | 12/28/2023 |
| Hively Brad | ▲ Buy | Grant | 42,652 | $0 | 12/26/2023 |
| Johnson Karen Marie | ▲ Buy | Grant | 52,000 | $0 | 12/26/2023 |
| Kaushal Mohit | ▲ Buy | Grant | 53,326 | $0 | 12/26/2023 |
| Ling Gabriel | ▲ Buy | Grant | 40,000 | $0 | 12/26/2023 |
| Anne McGeorge | ▲ Buy | Grant | 56,000 | $0 | 12/26/2023 |
| Pacala Mark L | ▲ Buy | Grant | 46,630 | $0 | 12/26/2023 |
| BARASCH RICHARD A | ▲ Buy | Grant | 80,000 | $0 | 12/26/2023 |
| O'Meara Maeve | ▲ Buy | Grant | 50,000 | $0 | 12/26/2023 |
| Shah Mihir | ▲ Buy | Open Market | 99,435 | $126K | 12/14/2023 |
| Shah Mihir | ▲ Buy | Open Market | 565 | $706 | 12/14/2023 |
| Castle Jeremy | ▲ Buy | Grant | 12,340 | $0 | 11/30/2023 |
| Hively Brad | ▼ Sell | Other | 25,867 | $57K | 11/21/2023 |
| Virnich Daniel | ▼ Sell | Other | 4,322 | $9K | 11/21/2023 |
| Podnos Yale | ▼ Sell | Other | 1,530 | $3K | 11/21/2023 |
| Hively Brad | ▲ Buy | Option Exercise | 25,000 | $21K | 11/17/2023 |
| Hively Brad | ▼ Sell | Open Market | 25,000 | $56K | 11/17/2023 |
| Hively Brad | ▼ Sell | Other | 27,117 | $65K | 11/14/2023 |
| Podnos Yale | ▼ Sell | Other | 238 | $568 | 11/14/2023 |
| Podnos Yale | ▼ Sell | Other | 1,860 | $4K | 11/14/2023 |
| Virnich Daniel | ▼ Sell | Other | 4,604 | $11K | 11/14/2023 |
| Hively Brad | ▲ Buy | Option Exercise | 47,000 | $40K | 11/13/2023 |
| Hively Brad | ▼ Sell | Open Market | 47,000 | $119K | 11/13/2023 |
| Shah Mihir | ▼ Sell | Other | 2,573 | $1K | 5/23/2023 |
| Shah Mihir | ▼ Sell | Other | 869 | $372 | 5/23/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 2,146 | $1K | 3/17/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 10,000 | $6K | 3/17/2023 |
| Shah Mihir | ▲ Buy | Grant | 176,191 | $0 | 3/17/2023 |
| Miller Matthew P | ▲ Buy | Grant | 67,667 | $0 | 3/17/2023 |
| SARIN RAVI YANG | ▲ Buy | Grant | 29,528 | $0 | 3/17/2023 |
| Virnich Daniel | ▲ Buy | Grant | 114,944 | $0 | 3/17/2023 |
| O'Meara Maeve | ▲ Buy | Grant | 16,404 | $0 | 3/17/2023 |
| Anne McGeorge | ▲ Buy | Grant | 26,247 | $0 | 3/17/2023 |
| Pacala Mark L | ▲ Buy | Grant | 6,562 | $0 | 3/17/2023 |
| Johnson Karen Marie | ▲ Buy | Grant | 19,685 | $0 | 3/17/2023 |
| Hively Brad | ▲ Buy | Grant | 168,512 | $0 | 3/17/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 10,000 | $6K | 3/17/2023 |
| Podnos Yale | ▲ Buy | Grant | 33,219 | $0 | 3/17/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 10,000 | $6K | 3/17/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 52 | $29 | 3/17/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 200 | $110 | 3/17/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 9,948 | $5K | 3/17/2023 |
| BARASCH RICHARD A | ▲ Buy | Open Market | 7,654 | $4K | 3/17/2023 |
| Kaushal Mohit | ▲ Buy | Grant | 19,685 | $0 | 3/17/2023 |
| Miller Matthew P | ▲ Buy | Open Market | 73,684 | $70K | 12/16/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Starling Oncology reports stronger cash flow and gross profit
Starling Oncology disclosed higher cash flow and gross profit in its latest results. The improvement has prompted analysts to consider a re‑rating of the stock. The company’s financial metrics are now better positioned relative to its recent price range.
Starling Oncology reports stronger cash flow and gross profit. Starling Oncology disclosed higher cash flow and gross profit in its latest results. The improvement has prompted analysts to consider a re‑rating of the stock. The company’s financial metrics are now better positioned relative to its recent price range.